Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Galantamine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Galantamine 16mg modified-release capsules
0411000F0AAAFAF
|
Galantamine | Galantamine | Central Nervous System | 6,586 |
|
Galantamine 24mg modified-release capsules
0411000F0AAAGAG
|
Galantamine | Galantamine | Central Nervous System | 4,243 |
|
Galantamine 8mg modified-release capsules
0411000F0AAAEAE
|
Galantamine | Galantamine | Central Nervous System | 2,794 |
|
Galantamine 20mg/5ml oral solution sugar free
0411000F0AAADAD
|
Galantamine | Galantamine | Central Nervous System | 1,129 |
|
Galantamine 8mg tablets
0411000F0AAABAB
|
Galantamine | Galantamine | Central Nervous System | 35 |
|
Galantamine 12mg tablets
0411000F0AAACAC
|
Galantamine | Galantamine | Central Nervous System | 10 |
|
Galantamine 4mg tablets
0411000F0AAAAAA
|
Galantamine | Galantamine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.